However, by using MDA-MB-231 breast cancer cells, cocultured with endothelial cells, Nakano et al (2004) have shown that HRG2 is involved in an inhibitory effect on angiogenesis in vitro as well as in vivo. This evidence concerns the gene NRG2 and breast carcinoma.